Crystallization (Comment) | Organism |
---|---|
hanging drop vapor diffusion method, 18°C | Clostridium perfringens |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Clostridium perfringens | - |
strain ATCC 10543 | - |
Purification (Comment) | Organism |
---|---|
immobilized metal affinity chromatography | Clostridium perfringens |
Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|
additional information | - |
2-3fold preference for blood group A antigen | Clostridium perfringens |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
Galalpha(1-3)[Fucalpha(1-2)]Galbeta(1-4)GlcNAcbeta-CH2-CH2-N3 + H2O | analog of blood group B antigen | Clostridium perfringens | ? | - |
? | |
GalNAcalpha(1-3)[Fucalpha(1-2)]Galbeta(1-4)GlcNAcbeta-CH2-CH2-N3 + H2O | analog of blood group A antigen | Clostridium perfringens | ? | - |
? |
Synonyms | Comment | Organism |
---|---|---|
blood group A/B antigen-specific endo-beta-galactosidase | - |
Clostridium perfringens |
GH98CBM51 | - |
Clostridium perfringens |